.OncoC4 is taking AcroImmune-- as well as its own internal professional production functionalities--...
.Amgen has actually discussed (PDF) the 1st period 3 data on its $400 million eczema medication, con...
.Biogen and UCB's depend developing in to stage 3 on the back of a broken study looks to have actual...
.Italian biotech Aptadir Rehabs has launched with the pledge that its own pipeline of preclinical RN...
.Wave Lifestyle Sciences has actually satisfied its own objective in a Duchenne muscle dystrophy (DM...
.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, using...